Amelioration of glucose homeostasis and visceral adiposity in type 2 diabetes by mild electrical current and thermo therapy

Amelioration of glucose homeostasis and visceral adiposity in type 2 diabetes by mild electrical current and thermo therapy - Metabolic ameliorations in T2DM by MET

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003210

Enrollment

Registered

2010-04-01

Start date

2010-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

12 weeks of MET (4 times a week, 60 min each time), and then 12 weeks of withdrawal, 20 subjects. 12 weeks of no treatment, and then 12 weeks of MET (4 times a week, 60 min each time), 20 subjects.

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: T2DM patients having waist circumference greater than 85 cm with HbA1c, greater than or equal 6.5%, and less than 9.0%.

Exclusion criteria

Exclusion criteria: i) Past history or current medication of myocardial infarction, angina, apoplexy and arteriosclerosis obliterans. ii)Severe wound, infections, pre- or post-operation. iii)Severe liver dysfunction (GOT and/or GPT: greater than 100U). iv)Chronic heart failure, familial dyslipidemia. v)Severe diabetic complications. vi)Pacemaker carrier.

Design outcomes

Primary

Measure	Time frame
Changes of biomarkers related to T2DM at 12 weeks and 24 weeks after MET treatment.	—

Secondary

Measure	Time frame
General assessment of MET device evaluated by subjects.	—

Countries

Japan

Contacts

Public ContactTatsuya Kondo

Faculty of Life Sciences, Kumamoto University Department of Metabolic Medicine

t-kondo@gpo.kumamoto-u.ac.jp096-373-5169

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026